NephroGenex, Inc.

 

  Follow

Location: USA

Founded in 2004

Publicly Traded


"NephroGenex is developing pharmaceuticals against certain kidney diseases."
Description Source: VentureRadar Research / Company Website

Funding Signals


VENTURE FUNDED

HealthCapKarolinska DevelopmentRho VenturesVentureRadar Research / Company Website

SPIN-OFF

Export Similar Companies

Similar Companies


Company Country Status Description
Akebia TherapeuticsUSAPublicly Traded
Akebia Therapeutics is a biotech company that is based in Cincinnati, OH and was spun out of Procter & Gamble Pharmaceuticals in 2007. The Company's lead program, AKB-6548, is an...
PraetegoUSAPrivately Held
Praetego is a preclinical stage pharmaceutical company committed to addressing serious diabetic complications. Our novel and proprietary small molecule candidates target a common...
Anthera Pharmaceuticals, Inc.USAPublicly Traded
Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical...
Alebund PharmaceuticalsChinaPrivately Held
Alebund Pharmaceuticals is a Shangai, China-based biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic...
Conatus PharmaceuticalsUSAPublicly Traded
Conatus Pharmaceuticals was founded in July 2005 by a cohesive and experienced team with a proven track-record in hepatology, infectious diseases and inflammation, including the...
AngiosAustriaPrivately Held
Angios is developing new treatments for challenging vascular diseases using the vascular organoid model developed by the company’s founders. The vascular organoids allow the...
Show all
VentureRadar Score

Is this your company?

Claim this profile and
update details for free
Sub-Scores
Social Proof
580
Website Traffic
930
Auto Analyst Score
500
Popularity on VentureRadar
859
Website Popularity
Low Traffic Sites
Low
High Traffic Sites
High
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Open PageRank: 687,145 | nephrogenex.com
Auto Analyst Score
50
Auto Analyst Score: 50 | nephrogenex.com
VentureRadar Popularity
Medium
VentureRadar Popularity: Medium
The popularity score combines profile views, clicks and the number of times the company appears in search results.

Free Sign-up for VentureRadar access

or






By continuing, you agree to VentureRadar's Terms of Service, Privacy Policy and Cookie Policy.

To continue, please confirm you are not a robot